This is an application for the Tumor Microenvironment Network from a highly collaborative group of investigators from Columbia University who have worthed together for over 5 years on the tumor microenvironment. The focus of the program is the role of myofibroblasts (MF)/cancer-associated fibroblasts (CAF) in digestive cancers, and includes studies of gastric, hepatocellular and pancreatic cancer. The three cancers are among the most common and lethal of solid tumors, and evidence suggests that each is strongly promoted at early stages by alpha-SMA+ fibroblastic cells. In addition, recent work suggests that Helicobacter-dependent gastric cancer is promoted by CAFs that are derived from bone marrow derived mesenchymal stem cell (MSCs) and that contribute to the MSC and tumor niche;that hepatocellular cancer is promoted by myofibroblasts that are activated by the microbiome and TLR4 signaling;and that CAFs in digestive cancers show early global DNA hypomethylation with focal gains or promoter methylation, that results in a unique susceptibility to further loss of DNA methylation. Based on these and other observations, three highly interactive projects are proposed. Project 1 (Wang) will further explore the MSC origin of gastric cancer MF/CAFs, their interaction with microbiome signals, their contribution to cancer growth, and the mechanism of hypomethylation;Project 2 (Schwabe) will explore the role of damage-associated molecular patterns (DAMPs), TLR4, and the microbiome to the tumor-promoting myofibroblast niche;Project 3 (Tycko) will examine the relationship of pancreatic and hepatocellular CAF hypomethylation to changes in gene expression and in vivo behavior, and examine the effects of decitabine or conditional Dnmtl KO in CAFs on prevention of tumor progression. The three projects will jointly address the three major themes which are the origins of CAFs, their activation by the gut microbiome, and the role of DNA hypomethylation. The three projects are supported by an Administrative/Bioinformatics Core and by a Germ-Free Mouse Core at MIT. The three projects are highly translational with heavy use of human tissues and physiological mouse models of digestive cancers, and are linked to a Phase 1 clinical trial in human patients with pancreatic cancer.

Public Health Relevance

This study will address the origins and importance of stromal fibroblasts in gastric cancer, liver cancer and pancreatic cancer with a particular focus on the role of commensal bacteria, DNA methylation and the origins of stromal fibroblasts. Understanding how cancer fibroblasts arise and the ways in which they contribute to the growth of tumors will clarify the utility and proper design of therapies targeted to the stroma.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-3 (O1))
Program Officer
Ogunbiyi, Peter
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Huebener, Peter; Gwak, Geum-Youn; Pradere, Jean-Philippe et al. (2014) High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab 19:539-47
Luedde, Tom; Kaplowitz, Neil; Schwabe, Robert F (2014) Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147:765-783.e4
Schwabe, Robert F; Jobin, Christian (2013) The microbiome and cancer. Nat Rev Cancer 13:800-12
Shakya, Reena; Gonda, Tamas; Quante, Michael et al. (2013) Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. Cancer Res 73:885-96
Quante, Michael; Varga, Julia; Wang, Timothy C et al. (2013) The gastrointestinal tumor microenvironment. Gastroenterology 145:63-78
Pradere, Jean-Philippe; Kluwe, Johannes; De Minicis, Samuele et al. (2013) Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 58:1461-73
Dapito, Dianne H; Mencin, Ali; Gwak, Geum-Youn et al. (2012) Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21:504-16